Exposure Dose Guidance for Water Ingestion, V1 – Jan 31, 2023
9
Tendency and
Reasonable
Maximum
Exposure
Dose
Estimates
(CTE/ RME)
To represent persons with typical and high-end exposures, estimate typical
exposure doses for receptors using CTE intake values and rates and high-end
doses for receptors using a combination of CTE and RME values and rates.
When feasible, you can present the results as a range of doses in the target
population. The EPA’s EFH is the primary source for CTE and RME tap
water intake rates in children and adults (EPA 2019).
Discussion in the public health implications section of your document should
include your explanation for estimates for both children and adults. For
example, if the risk of harmful effects is only for children with high intake
rates (RME), describe the risk of harm for that group and explain that children
with typical intake rates (CTE) are not at risk. Likewise, if the risk of harmful
effects is for both groups, your estimate explanation should reflect both
scenarios.
When evaluating noncancer endpoints, you should estimate doses for the
most highly exposed group (e.g., for drinking water, usually children birth to
1 yr) or for the most sensitive group. If the estimated dose for these groups
exceeds the health guideline (e.g., MRL, RfD), then evaluate doses for other
groups. Remember that when evaluating cancer risk, you should use site-
specific information to identify the age ranges for which you need cancer risk
estimates, whenever possible.
Public Health
Assessment
Site Tool
(PHAST)
Health assessors should use the public health assessment site tool (PHAST) to
estimate drinking water doses. PHAST provides a quick summary with the
maximum hazard quotient for chronic, intermediate, and acute exposure as
well as the maximum cancer risk for the typical residential exposure scenario
involving children and adults.
If the HQ exceeds one, review the age-specific dose and hazard quotient
calculations to evaluate risk of noncancerous effects in children and adults.
If no MRL or RfD is available, compare the maximum age-specific dose
directly to NOAELs and LOAELs to determine the possibility of harmful
effects. If you decide harmful effects are possible, consider doses for all age
ranges to determine who is at risk of noncancerous harmful effects.
The default cancer risk calculation in the quick summary assumes 33 years of
residential exposure—the 95
th
percentile residential-occupancy period. The
default 33-year cancer risk assumes 21 years of exposure as a child, followed
by 12 years of exposure as an adult at the same residence. If the maximum
cancer risk in the quick summary exceeds 1E-6, review the cancer risks for
children and adults from the more detailed cancer risks in the results table.
Remember that the quick summary cancer risk is a screen – you should not
include it in PHAs/HCs unless you have an exposure scenario where children
grow up in a house or area and continue to have the same exposure as adults.